Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacterial diversity of the Colombian fermented milk “Suero Costeño” assessed by culturing and high-throughput sequencing and DGGE analysis of 16S rRNA gene amplicons

  • Motato, Karina Edith
  • Milani, Christian
  • Ventura, Marco
  • Valencia, Francia Elena
  • Ruas-Madiedo, Patricia
  • Delgado, Susana
“Suero Costeño” (SC) is a traditional soured cream elaborated from raw milk in the Northern-Caribbean coast of Colombia. The natural microbiota that characterizes this popular Colombian fermented milk is unknown, although several culturing studies have previously been attempted. In this work, the microbiota associated with SC from three manufacturers in two regions, “Planeta Rica” (Córdoba) and “Caucasia” (Antioquia), was analysed by means of culturing methods in combination with high-throughput sequencing and DGGE analysis of 16S rRNA gene amplicons. The bacterial ecosystem of SC samples was revealed to be composed of lactic acid bacteria belonging to the Streptococcaceae and Lactobacillaceae families; the proportions and genera varying among manufacturers and region of elaboration. Members of the Lactobacillus acidophilus group, Lactocococcus lactis, Streptococcus infantarius and Streptococcus salivarius characterized this artisanal product. In comparison with culturing, the use of molecular in deep culture-independent techniques provides a more realistic picture of the overall bacterial communities residing in SC. Besides the descriptive purpose, these approaches will facilitate a rational strategy to follow (culture media and growing conditions) for the isolation of indigenous strains that allow standardization in the manufacture of SC., This study was supported by Spanish Ministry of Economy and Competitiveness partially funded by European Union FEDER (project reference AGL2015-64901-R). The cooperation project COOPA20057 (funded by CSIC), between IPLA-CSIC (Spain) and Antioquia University (Colombia) allowed several short stays of K.E. Motato at IPLA-CSIC. S. Deldado is supported by a Postdoctoral research contract associated to a project from the Spanish “Plan Estatal de I+D+ i” research plan (project reference BIO2014-55019-JIN), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bifidobacteria and their health-promoting effects

  • Hidalgo-Cantabrana, Claudio
  • Delgado, Susana
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
  • Sánchez García, Borja
Bifidobacteria are members of the intestinal microbiota of mammals and other animals, and some strains are able to exert health-promoting effects. The genus Bifidobacterium belongs to the Actinobacteria phylum. Firmicutes, Bacteroidetes, and Actinobacteria constitute the most abundant phyla in the human intestinal microbiota, Firmicutes and Bacteroidetes being predominant in adults, and Actinobacteria in breast-fed infants, where bifidobacteria can reach levels higher than 90% of the total bacterial population. They are among the first microbial colonizers of the intestines of newborns, and play key roles in the development of their physiology, including maturation of the immune system and use of dietary components. Indeed, some nutrients, such as human milk oligosaccharides, are important drivers of bifidobacterial development. Some Bifidobacterium strains are considered probiotic microorganisms because of their beneficial effects, and they have been included as bioactive ingredients in functional foods, mainly dairy products, as well as in food supplements and pharma products, alone, or together with, other microbes or microbial substrates. Well-documented scientific evidence of their activities is currently available for bifidobacteria-containing preparations in some intestinal and extraintestinal pathologies. In this review, we focus on the role of bifidobacteria as members of the human intestinal microbiota and their use as probiotics in the prevention and treatment of disease., Research in our group is supported by grants AGL2015- 64901-R, BIO2014-55019-JIN, AGL2013-44761-P, and AGL2013-44039-R from the Spanish Ministry of Economy and Competitiveness, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bifidobacteria and their molecular communication with the immune system

  • Ruíz García, Lorena
  • Delgado, Susana
  • Ruas-Madiedo, Patricia
  • Sánchez García, Borja
  • Margolles Barros, Abelardo
Bifidobacterium represents a genus within the phylum Actinobacteria which is one of the major phyla in the healthy intestinal tract of humans. Bifidobacterium is one of the most abundant genera in adults, but its predominance is even more pronounced in infants, especially during lactation, when they can constitute the majority of the total bacterial population. They are one of the pioneering colonizers of the early gut microbiota, and they are known to play important roles in the metabolism of dietary components, otherwise indigestible in the upper parts of the intestine, and in the maturation of the immune system. Bifidobacteria have been shown to interact with human immune cells and to modulate specific pathways, involving innate and adaptive immune processes. In this mini-review, we provide an overview of the current knowledge on the immunomodulatory properties of bifidobacteria and the mechanisms and molecular players underlying these processes, focusing on the corresponding implications for human health. We deal with in vitro models suitable for studying strain-specific immunomodulatory activities. These include peripheral blood mononuclear cells and T cell-mediated immune responses, both effector and regulatory cell responses, as well as the modulation of the phenotype of dendritic cells, among others. Furthermore, preclinical studies, mainly germ-free, gnotobiotic, and conventional murine models, and human clinical trials, are also discussed. Finally, we highlight evidence supporting the immunomodulatory effects of bifidobacterial molecules (proteins and peptides, exopolysaccharides, metabolites, and DNA), as well as the role of bifidobacterial metabolism in maintaining immune homeostasis through cross-feeding mechanisms., LR is a postdoctoral researcher supported by the Juan de la Cierva Postdoctoral Trainee Program of the Spanish Ministry of Economy and Competitiveness (MINECO; IJCI-2015-23196). BS and AM thanks MINECO for the funding of the project AGL2016-78311-R and PR-M for the project AGL2015-64901-R. SD is supported by a research contract associated to the project BIO2014-55019-JIN from the Spanish “Plan Estatal de I+D+i”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Evaluación de distintos métodos y condiciones de preservación de microbiota fecal viable

  • Delgado, Susana
  • Díaz, María
  • Ruas-Madiedo, Patricia
  • Martínez Álvarez, Noelia
  • Hidalgo-Cantabrana, Claudio
  • Sánchez García, Borja
  • Margolles Barros, Abelardo
Trabajo presentado en la 11ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Gijón (Asturias, España) del 28 al 30 de Junio de 2017, [Introducción] Actualmente existe muy poca información acerca del efecto de la congelación sobre la viabilidad de la microbiota fecal, y hasta la fecha, no se ha realizado ninguna investigación para determinar las condiciones y compuestos más adecuados para criopreservar y maximizar la viabilidad microbiana durante la conservación de esta microbiota. La preservación de muestras complejas de microbiota puede ser de utilidad para recuperar microorganismos de interés, así como ahondar en estudios de microbiota intestinal mediante el empleo de modelos in vitro e in vivo sin necesidad de depender de muestras fecales frescas. [Objetivos] En el presente trabajo se analizó el papel de distintos criopreservantes y condiciones de congelación en muestras de microbiota intestinal extraída de heces, evaluándose el mantenimiento de la viabilidad y recuperación de la microbiota en su conjunto, así como de distintas poblaciones representativas a los 3 meses de su preservación. [Materiales y Métodos] A partir de 5 muestras de heces de donantes voluntarios sanos se obtuvo la microbiota fecal mediante un procedimiento de separación en gradiente de densidad por ultracentrifugación previamente descrito (Hevia y cols., 2015). Las muestras, procesadas en una estación de trabajo en anaerobiosis, se alicuotaron y se guardaron congeladas bajo 4 condiciones experimentales: A) en presencia de glicerol al 15% a -20°C; B) con glicerol al 20% a -80°C; C) con sacarosa al 10% a -80°C y D) con polietilenglicol (PEG) al 20% a -196°C. Se evaluó la viabilidad de la microbiota extraída antes y después de ser preservada mediante recuentos en placa en distintos medios, microscopia de fluorescencia (kit ¿Live/Dead BacLight¿) y mediante qPCR usando monoazida de propidio (PMA) para la detección de células no dañadas. [Resultados] Al comparar de forma global las cuatro condiciones de preservación se observó una diferencia significativa entre las distintas condiciones en cuanto a la reducción de los recuentos en placa, con una mayor pérdida cuando la microbiota extraída es preservada en glicerol y menor cuando la congelación se realizó a -196°C. El conteo total de células vivas mediante microscopia después de la conservación reveló reducciones de en torno a una unidad logarítmica con un mayor porcentaje de células vivas tras la congelación en nitrógeno líquido, en concordancia con los resultados de cultivo. El análisis por qPCR, previo tratamiento con PMA, de distintos grupos microbianos mostró variaciones en función de las muestras procedentes de los distintos donantes. Para las bifidobacterias y el grupo de Clostridium XIVa se observaron mayores diferencias entre las condiciones de preservación, con mayores niveles cuantificados en presencia de PEG a -196°C. [Conclusiones] Aunque es preciso ampliar con más muestras y analizar la viabilidad tras periodos de tiempo más largo de conservación, los resultados obtenidos muestran una mejor preservación de la microbiota fecal en su conjunto a temperaturas ultrabajas., Proyecto I+D+I para jóvenes investigadores MINECO (Ref: BIO2014-55019-JIN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Fecal Microbiota transplantation: Historical perspective and future trends

  • Margolles Barros, Abelardo
  • Sánchez García, Borja
  • Ruas-Madiedo, Patricia
  • Delgado, Susana
  • Ruíz García, Lorena
Trabajo presentado en el 10th Workshop on Probiotics and Prebiotics, de la Sociedad Española de Probióticos y Prebióticos (SEPyP), celebrado en Las Palmas de Gran Canarias, del 6 al 8 de febrero de 2019, The human gut microbiota is composed of the different microorganisms of our intestinal ecosystem. It has an important metabolic and nutritional role, and it is involved in the correct development of the gut and the maturation of our immune system. Currently, the application of fecal microbiota transplantation (FMT) has allowed us to establish causality in microbiome studies, and we know that microbiota can cure diseases or induce the appearance of disease symptoms, or even determine the success of some health treatments. But knowledge of the curative effects of feces has been documented many centuries ago. In the present article we want to make a brief review of the history of FMT, focusing on its effect on the human microbiome and its capacity to act on human physiology. We also want to place special emphasis on aspects that must be taken into account to translate microbiome research to medicine, related to safety, regulation and standardization of methods, as well as the importance of being able to predict the success of FMT., Research in our group is funded by grants BIO2014-55019-JIN and AGL2016-78311-R (from the Spanish Ministry of Economy and Competitiveness) and a grant from the Asociación Española contra el Cáncer (Reference: PS2016). Lorena Ruiz is the recipient of a Juan de la Cierva Post-Doctoral contract (IJCI-2015-23196) from the Spanish Ministry of Economy and Competitiveness